Radiotherapy Chemotherapy Equipment & Supplies
8 equipment items found
Manufactured by:Laboratoire Lideal Parisien Sp. z o.o. based inNiegoszowice, POLAND
General information and indications for useIntended for women of childbearing age and menopausal women to help relieve discomfort and dryness, tension, itching, and burning of the vaginal mucosa linked ...
by:Carina Biotech based inMawson Lakes, AUSTRALIA
Advanced colorectal cancer currently has a poor prognosis and is the deadliest form of cancer for Australians 25 to 34 years old. LGR5 is a cancer stem cell marker that is highly expressed on advanced colorectal cancer and other cancers. In colon cancer patients, LGR5+ expression has been correlated with a particularly poor ...
Manufactured by:Hybio Pharmaceutical Co., Ltd. based inGuangdong, CHINA
1 mg: Hasten T cell differentiation,reinforce immune function of tumor patients; Boost NK cell cytoactivity,two-ways regulation of immune function in case of active hepatitis; Contain virus replication,treat chroic Hepatitis B; Used both in IV drop and intramuscular injection. 10 mg: Particlarly indicated for adjuvant therapy of malignant carcinoma cases under chemotherapy & ...
Manufactured by:Laboratoire Lideal Parisien Sp. z o.o. based inNiegoszowice, POLAND
General information and indications for use: Intended for women in their reproductive years and during menopause, in order to alleviate the symptoms of vaginal dryness (discomfort, tension, itching, burning of vaginal mucous membranes) related ...
Manufactured by:TVAX Biomedical, Inc. based inOlathe, KANSAS (USA)
TVAX®’s lead candidate (TVI-Brain-1) is being evaluated for the treatment of brain cancer and targets glioblastomas. The drug candidate has received Fast Track Designation by the US Food and Drug Administration (FDA) to test TVI-Brain-1 in a Phase 2b clinical study for glioblastoma multiforme (GBM). The Fast Track Designation is supported by positive Phase 2 clinical data, as well as ...
Manufactured by:BetaGlue Technologies SpA based inMilano, ITALY
Surgery is the standard of care for resectable solid tumors. Loco-regional approaches, in combination with chemotherapy and/or radiotherapy, are standard therapy in the following ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
Worldwide, almost 297,000 cases of brain and nervous system tumors are diagnosed per year. Glioblastoma (GBM) is the most common and aggressive type of malignant primary brain tumor, with a median survival of 10-12 months. Treatment for brain tumors typically involves surgical removal, followed by radiation therapy or chemotherapy. Xoft brain IORT is a promising treatment option that may offer ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
RLX demonstrates the ability to improve the retention time of therapeutic agents within the tumor microenvironment by utilizing advanced nanoparticle delivery systems. RLX can be integrated with various treatment modalities, such as chemotherapy and radiotherapy, to enhance overall tumor therapy effectiveness. RLX highlights the necessity for further research ...